Finance

Lists
688050:SHA
Eyebright Medical Technlgy (Bjng) Co Ltd
CNÂ¥40.25
+0.98%
(+0.39) 1D
Sep 8, 3:00:03 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688050...
Open
CNÂ¥39.80
High
CNÂ¥40.46
Low
CNÂ¥39.60
Mkt. cap
7.61B
Avg. vol.
3.26M
Volume
1.63M
Dividend
0.80%
Quarterly dividend
CNÂ¥0.08
Ex-dividend date
Jun 22, 2026
P/E ratio
33.07
52-wk high
CNÂ¥83.83
52-wk low
CNÂ¥35.23
EPS
CNÂ¥1.22
No. of employees
2K
Open
CNÂ¥39.80
High
CNÂ¥40.46
Low
CNÂ¥39.60
Mkt. cap
7.61B
Avg. vol.
3.26M
Volume
1.63M
Dividend
0.80%
Quarterly dividend
CNÂ¥0.08
Ex-dividend date
Jun 22, 2026
P/E ratio
33.07
52-wk high
CNÂ¥83.83
52-wk low
CNÂ¥35.23
EPS
CNÂ¥1.22
No. of employees
2K
About Eyebright Medical Technlgy (Bjng) Co Ltd
CEO-
Employees2.33K
FoundedApr 21, 2010
Headquarters-
SectorMedical device
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
357.72M
338.29M
398.24M
534.52M
Cost of goods sold
127.55M
153.70M
153.40M
205.24M
Cost of revenue
127.55M
153.70M
153.40M
205.24M
Research and development expenses
21.42M
24.44M
18.59M
33.55M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
116.70M
119.17M
112.48M
177.75M
Operating expense
142.60M
154.48M
140.81M
200.48M
Total operating expenses
270.15M
308.18M
294.21M
405.72M
Operating income
87.57M
30.11M
104.03M
128.80M
Other non operating income
1.65M
-2.64M
-1.86M
-22.96M
EBT including unusual items
80.85M
-33.14M
98.65M
111.75M
EBT excluding unusual items
83.44M
23.97M
98.00M
111.42M
Income tax expense
9.11M
4.89M
12.84M
16.31M
Effective tax rate
11.26%
-14.76%
13.01%
14.60%
Other operating expenses
1.01M
12.42M
1.52M
-2.60M
Net income
76.85M
-21.99M
89.28M
93.33M
Net profit margin
21.48%
-6.50%
22.42%
17.46%
Earnings per share
0.38
-0.14
-
-
Interest and investment income
1.28M
1.71M
1.64M
5.82M
Interest expense
-5.22M
-6.00M
-5.82M
-250.37K
Net interest expenses
-3.94M
-4.29M
-4.18M
5.57M
Depreciation and amortization charges
-
-
-
-
EBITDA
119.61M
69.98M
143.91M
169.21M
Gain or loss from assets sale
-141.56K
93.89K
-
-393.60K
AI content may include mistakes. Learn more
Google apps